Arcus Biosciences, Inc. (RCUS)
NYSEHealth CareBiotechnologySnapshot 2026-09-04
$29.66-1.56%
Close 2026-09-04 · 1-day change
NYSEHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · RCUS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | 117.0 | 247.0 | 258.0 | 117.0 | 112.0 | 383.0 | 78.0 | 15.0 | 8.4 |
| Total Revenues | 117.0 | 247.0 | 258.0 | 117.0 | 112.0 | — | — | 15.0 | 8.4 |
| Operating Expenses & Income | |||||||||
| R&D Expenses | 497.0 | 523.0 | 448.0 | 340.0 | 288.0 | 257.0 | 159.0 | 78.5 | 49.6 |
| Operating Income | (486.0) | (386.0) | (330.0) | (340.0) | (280.0) | 54.0 | (124.0) | (88.7) | (54.9) |
| Earnings from Continuing Operations | |||||||||
| Interest Expense | — | 8.0 | 4.0 | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | 26.0 | 33.0 | 48.0 | 39.0 | 14.0 | 1.0 | 1.0 | 4.0 | 5.3 |
| EBT, Incl. Unusual Items | (460.0) | (353.0) | (282.0) | (301.0) | (266.0) | 55.0 | (123.0) | — | — |
| Income Tax Expense | — | — | 1.0 | 6.0 | 1.0 | 2.0 | — | — | — |
| Net Income | |||||||||
| Net Income | (460.0) | (353.0) | (283.0) | (307.0) | (267.0) | 53.0 | (123.0) | (84.7) | (49.6) |
| Per Share | |||||||||
| Basic EPS | (3.65) | (3.29) | (3.14) | (4.15) | (3.71) | 0.76 | (2.24) | — | — |
| Diluted EPS | (3.65) | (3.29) | (3.14) | (4.15) | (3.71) | 0.71 | (2.24) | — | — |
| Revenue per Share | 0.93 | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 126.1 | 107.4 | 90.1 | 74.0 | 72.0 | 69.3 | 54.8 | 43.8 | 36.4 |
| Diluted Weighted Avg Shares | 126.1 | 107.4 | 90.1 | 74.0 | 72.0 | 74.0 | 54.8 | — | — |
| Supplemental | |||||||||
| EBITDA | — | (376.0) | (320.0) | (332.0) | (274.0) | 58.0 | (121.0) | (85.1) | (51.2) |
| EBIT | (486.0) | (386.0) | (330.0) | (340.0) | (280.0) | 54.0 | (124.0) | (88.7) | (54.9) |
| Effective Tax Rate | — | — | — | -2.0% | -0.4% | 3.6% | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.